Escolar Documentos
Profissional Documentos
Cultura Documentos
John MF
Adam
TREATMENT OF DIABETES
MELLITUS
Non-pharmacology
Medical nutrition therapy,
Exercise or
increased activity
Pharmacology
Oral hypoglycemic agents
Insulin
Education
1
%
REDUCED
RISK*
Deaths from
diabetes
-21%
Heart
attacks
-14%
Microvascular
complications
-37%
Peripheral vascular
disorders
-43%
*p<0.0001
Frederick
Banting
and
Charles Best
(Toronto, 1921)
Marjori
e
The insulin
1922 -- 2013
Leonard Thompson
CHANGING PATTERN
OF TYPE 2 DIABETES MANAGEMENT
For decades the treatment depends on
the diabetic clinics or even personal
experience
Standard
treatment,
the
nonpharmacology and pharmacology, was
used since the invention of insulin and
oral anti-diabetic drugs
Even though, no international consensus
of
medical
management
of
hyperglycemia, how or which drug to
start
New OHA and new insulin,
needs
Old Book
JOSLINS
DIABETES
MELLITUS
Before 2006
there was no
algorithm
2. Insulin
Joslins Diabetes Mellitus, General plan of treatment
3. Oral hypoglycaemic agents
diabetes, Marble A et al, 1971
of
THE ALGORITHMS
First international algorithm, introduced
in 2006 by ADA and EASD
Since 2006, at least 4 algorithms was
introduced
by
the
International
Diabetes Association
All the algorithms, two important
informations:
Metformin, was the first line Anti-Diabetic
Agents
choose ??
STEP 1
No
Add Basal
Insulin
(Most effective)
STEP 2
No
STEP 3
A1C 7%
A1C 7%
Intensive
Insulin
No
Yes*
Add
Sulfonylurea
(Least
expensive)
Yes*
No
A1C 7%
Add Glitazone
A1C 7%
Yes*
Yes*
Yes*
Add Glitazone
(No
hypoglycemia)
No
A1C 7%
Add
Basal Insulin
No
Yes*
Add
Sulfonylurea
A1C 7%
Yes*
Initial drug
monotherapy
Metfomin
If needed to reach individualized HbA1c target after 3 months, proceed to two-drug combination (order not
meant to denote any specific preference)
Two-drug
combinations
Metfomin
+
SUb
Metfomin
+
TZD
Metfomin
+
DPP-4 I
Metfomin
+
Insulin basal
Metfomin
+
GLP-1 RA
If needed to reach individualized HbA1c target after 3 months, proceed to three-drug combination
(order not meant to denote any specific preference)
Three-drug
combinations
Metfomin
+
SUb
+
TZD
or
DPP-4 I
or
Insulind
or
GLP-1 RA
Metfomin
+
TZD
+
SUb
or
DPP-4 I
or
Insulind
or
GLP-1 RA
Metfomin
+
DPP-4 I
+
SUb
or
TZD
or
Insulind
Metfomin
+
Insulin basal
+
TZD
or
DPP-4 I
or
GLP-1 RA
Metfomin
+
GLP-1 RA
+
SUb
or
TZD
or
Insulind
If combination therapy that includes basal insulin has failed to achieve HbA1c target after 3-6 months,
proceed to more complex insulin strategy, usually in combination with one or two non-insulin agents
More complex
insulin strategies
THE INSULIN
THE ANALOG
INSULIN
Rapid acting insulin
Aspart (Novorapid), Glulisine
(Apidra ),
Lispro (Humalog)
Premix insulin
Novomix
Humalog Mix 25
Kadar insulin
plasma
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
KONSENSUS
Waktu
(jam)
Profil farmakokinetik insulin manusia dan
insulin analog
TERAPI INSULIN - PERKENI
INSULIN INJECTION
INSULIN EFFECT
Mornin
g
Breakfas
t
Lunch
dinner
Evening
Night
INSULIN EFFECT
BASAL INSULIN
Breakfast
Nigh
t
Detem
ir
Lunch
Dinner
INSULIN EFFECT
PREMIX INSULIN
INJECTION
Breakfas
t
Lunch
Premix = Novomix
Dinner
INDICATIONS OF INSULIN
FOR TYPE 2 DIABETES
Acute complications ketoacidosis etc
Diabetes and pregnancy
Diabetes and infections acute septic
infections, tuberculosis
Preparing for operation
Failed (poor control) with oral antidiabetic agents ( the most cases in
clinical practice )
INSULIN INITIATION
FOR THE TREATMENT OF HYPERGLYCEMIA
IN TYPE 2 DIABETETES MELLITUS
PATIENT- CENTERED APPROACH
ADA EASD STATEMENT 2012
INSULIN INITATION
FOR THE TREATMENT OF HYPERGLYCEMIA
IN TYPE 2 DIABETIC
Due to the beta-cell dysfunction that
characterizes type 2 diabetes, insulin
replacement
therapy
is
frequently
required (Int J Clin Pract 2008;62:845-857)
Ideally, the principle of insulin use is the
creation of as normal glycemic profile as
possible without unacceptable of weight
gain or hypoglycemia (Diabetology 2002;45:937938)
WHAT NEXT,
WHEN BASAL INSULIN
FAILS ?
Inadequate
Lifestyle
1 OAD
Initiate
2 OAD
3 OAD
Insulin
Initial drug
monotherapy
Metfomin
If needed to reach individualized HbA1c target after 3 months, proceed to two-drug combination (order not
meant to denote any specific preference)
Two-drug
combinations
Metfomin
+
SUb
Metfomin
+
TZD
Metfomin
+
DPP-4 I
Metfomin
+
Insulin basal
Metfomin
+
GLP-1 RA
If needed to reach individualized HbA1c target after 3 months, proceed to three-drug combination
(order not meant to denote any specific preference)
Three-drug
combinations
Metfomin
+
SUb
+
TZD
or
DPP-4 I
or
Insulind
or
GLP-1 RA
Metfomin
+
TZD
+
SUb
or
DPP-4 I
or
Insulind
or
GLP-1 RA
Metfomin
+
DPP-4 I
+
SUb
or
TZD
or
Insulind
Metfomin
+
Insulin basal
+
TZD
or
DPP-4 I
or
GLP-1 RA
Metfomin
+
GLP-1 RA
+
SUb
or
TZD
or
Insulind
If combination therapy that includes basal insulin has failed to achieve HbA1c target after 3-6 months,
proceed to more complex insulin strategy, usually in combination with one or two non-insulin agents
More complex
insulin strategies
WHAT NEXT
WHEN INSULIN BASAL FAILS ???
1. Basal insulin + 2 OAD ? - Metformin + TZD
2. Basal bolus insulin ?? - Levemir +
Novorapid
INTENSIFICATION
PROGRAMS
BASAL BOLUS
INSULIN
Intensification programs
4:00
insulin
Lunch
Breakfast
Dinner
Basal bolus
insulin
Breakfast Lunch
8:00
12:00
Dinner
Plasma insulin
Plasma insulin
Starting insulin
programs
Basal
4:00
8:00
12:00 16:00
Time
Intensification programs
Starting insulin
programs
Basal
Plasma insulin
insulin
Lunch
Breakfast
Basal bolus
insulin
Dinner
4:00
8:00
12:00
Basal bolus
insulin
8:00
Dinner
Plasma insulin
Breakfast Lunch
4:00
8:00
12:00 16:00
Time
Dinner
Plasma insulin
Breakfast Lunch
12:00 16:00
Time
INTENSIFICATION
PROGRAMS
Intensification programs
4:00
Intensified premixed
insulinLunch Dinner
BreakfastLunch
Breakfast
NovoRapi
d
Plasma insulin
Plasma insulin
Starting insulin
programs
Premixed
insulin
Lunch Dinner
Breakfast
8:00
4:00
8:00
Starting insulin programs for type 2 diabetes. Twice daily analogue premix.
Intensification programs : twice daily premixed analogue with prandial insulin added
at lunch. The background of each diagram depicts the normal pattern of insulin levels
in nondiabetic individuals eating 3 daily meals. The arrows show the progression from
starting to intensification insulin programs in the 4-T trial, as described in the text.
Leahy Jl. Insulin therapy in type 2 diabetes mellitus. In Endocrinology and Metabolism Clinics of North
America, Insulin Therapy. LeRoith D, Leahy JL, Cefalu WT, eds. Saunders company, Philadelphia,
Pennsylvania; 2012. P119 144.
WHAT NEXT,
WHEN BASAL INSULIN
FAILS ?
Non-insulin regimens
Number
Regimen
of injection complexity
Basal insulin + 1
(Mealtime) rapid-acting
insulin injection
Pre-mixed insulin
twice daily
More flexibel
Less flexibel
Low
Mod
3+
High
Flexibillity
Sequential insulin strategies in type 2 diabetes. Basal insulin alone is usually the optimal initial regimen, beginning at 0.10.2 units/kg body weight,
depending on the degree of hyperglycemia. It is usually prescribed in conjunction with one to two noninsulin agents. In patients willing to take more
than one injection and who have higher HbA1c levels ($9.0%), twicedaily premixed insulin or a more advanced basal plus mealtime insulin regimen
could also be considered (curved dashed arrow lines). When basal insulin has been titrated to an acceptable fasting glucose but HbA1c remains
above target, consider proceeding to basal plus mealtime insulin, consisting of one to three injections of rapid-acting analogs (see text for details). A
less studied alternativedprogression from basal insulin to a twice-daily premixed insulindcould be also considered (straight dashed arrow line); if
this is unsuccessful, move to basal plus mealtime insulin. Thegure describes the number of injections required at each stage, together with the
relative complexity and exibility. Once a strategy is initiated, titration of the insulin dose is important, with dose adjustments made based on the
prevailing glucose levels as reported by the patient. Noninsulin agents may be continued, although insulin secretagogues (sulfonylureas,
meglitinides) are typically stopped once more complex regimens beyond basal insulin are utilized. Comprehensive education regarding selfmonitoring of blood glucose, diet, exercise, and the avoidance of, and response to, hypoglycemia are critical in any patient on insulin therapy. Mod.,
moderate. Inzucchi SE, et al. Diabetes Care 2012; 19: 1-16
The
The
Pengobatan ??
Bolus - basal insulin
Diabetic ketoacidosis
Treatment
Continuous insulin drips
Rapid acting
Basal - bolus
MKS 28 04 2013
Intensification programs
4:00
Breakfast Lunch
Dinner
8:00
12:00
Prandial insulin
Breakfast Lunch
Dinner
4:00
Plasma insulin
4:00
8:00
12:00 16:00
Time
Dinner
Plasma insulin
Plasma insulin
Starting insulin
programs
Basal insulin
8:00
12:00 16:00
Time
Intensification programs
Dinner
Breakfast Lunch
Dinner
4:00 8:00
Plasma insulin
Plasma insulin
NovoRapid
4:00 8:00
Starting insulin programs for type 2 diabetes. Twice daily analogue premix. Intensification programs : twice
daily premixed analogue with prandial insulin added at lunch. The background of each diagram depicts the
normal pattern of insulin levels in nondiabetic individuals eating 3 daily meals. The arrows show the progression
from starting to intensification insulin programs in the 4-T trial, as described in the text. Leahy Jl. Insulin therapy in
type 2 diabetes mellitus. In Endocrinology and Metabolism Clinics of North America, Insulin Therapy. LeRoith D, Leahy JL, Cefalu
WT, eds. Saunders company, Philadelphia, Pennsylvania; 2012. P119 144.
Intensification programs
Basal bolus insulin
Dinner
Lunch
Plasma insulin
Breakfast
4:00
8:00
12:00
16:00
20:00
24:00
4:00
Time
Starting insulin programs for type 2 diabetes. Basal insulin, 3-times daily prandial insulin. Intensification
programs : basal bolus insulin. The background of each diagram depicts the normal pattern of insulin levels in
nondiabetic individuals eating 3 daily meals. The arrows show the progression from starting to intensification
insulin programs in the 4-T trial, as described in the text. Leahy Jl. Insulin therapy in type 2 diabetes mellitus. In
Endocrinology and Metabolism Clinics of North America, Insulin Therapy. LeRoith D, Leahy JL, Cefalu WT, eds. Saunders
company, Philadelphia, Pennsylvania; 2012. P119 144.
EVERY 1%
reduction in A1C
1%
REDUCED
RISK*
-21%
Heart attacks
-14%
Microvascular complications
-37%
-43%
*p<0.0001
Intensification
programs
4:00
Breakfast Lunch
Dinner
8:00
12:00
Prandial insulin
Breakfast Lunch
Dinner
4:00
Plasma insulin
4:00
8:00
12:00 16:00
Time
Dinner
Plasma insulin
Plasma insulin
Starting insulin
programs
Basal insulin
8:00
12:00 16:00
Time
Insulin basal
Makan
malam
Insulin plasma
4:00
Makan Makan
pagi
siang
Makan
malam
Insulin plasma
Makan Makan
pagi
siang
4:00
8:00
Insulin prandial
Makan
siang
Makan
malam
4:00
Makan
pagi
Makan
siang
Makan
malam
Insulin plasma
Insulin plasma
Makan
pagi
4:00